Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial

Safety and immunogenicity of modified vaccinia Ankara as a smallpox vaccine in people with atopic dermatitis

(2014) Frank von Sonnenburg et al.   VACCINE

Phase II randomized, double-blinded comparison of a single high dose (5×108 TCID50) of modified vaccinia Ankara compared to a standard dose (1×108 TCID50) in healthy vaccinia-naïve individuals

(2014) Sharon E. Frey et al.   VACCINE

Prospective Surveillance for Cardiac Adverse Events in Healthy Adults Receiving Modified Vaccinia Ankara Vaccines: A Systematic Review

(2013) Marnie L. Elizaga et al.   PLoS One

Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario

(2013) Sharon E. Frey et al.   VACCINE

Safety, Immunogenicity, and Surrogate Markers of Clinical Efficacy for Modified Vaccinia Ankara as a Smallpox Vaccine in HIV-Infected Subjects

(2012) R. N. Greenberg et al.   JOURNAL OF INFECTIOUS DISEASES

Unusual Features of Vaccinia Virus Extracellular Virion Form Neutralization Resistance Revealed in Human Antibody Responses to the Smallpox Vaccine

(2012) Mohammed Rafii-El-Idrissi Benhnia et al.   JOURNAL OF VIROLOGY

Evaluation of smallpox vaccines using variola neutralization

(2009) I. K. Damon et al.   JOURNAL OF GENERAL VIROLOGY

Modified vaccinia Ankara strains with identical coding sequences actually represent complex mixtures of viruses that determine the biological properties of each strain

(2009) Mark Suter et al.   VACCINE

A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE®

(2009) Alfred von Krempelhuber et al.   VACCINE

Vaccinia Virus Extracellular Enveloped Virion Neutralization In Vitro and Protection In Vivo Depend on Complement

(2008) M. R.-E.-I. Benhnia et al.   JOURNAL OF VIROLOGY

Surviving Mousepox Infection Requires the Complement System

(2008) Elizabeth A. Moulton et al.   PLoS Pathogens